183 related articles for article (PubMed ID: 31970936)
1. The mechanism of propofol in cancer development: An updated review.
Gao X; Mi Y; Guo N; Luan J; Xu H; Hu Z; Wang N; Zhang D; Gou X; Xu L
Asia Pac J Clin Oncol; 2020 Apr; 16(2):e3-e11. PubMed ID: 31970936
[TBL] [Abstract][Full Text] [Related]
2. Propofol Inhibits the Proliferation, Migration, and Stem-like Properties of Bladder Cancer Mainly by Suppressing the Hedgehog Pathway.
Li G; Zhang X; Guo X; Li Y; Li C
Cell Transplant; 2021; 30():963689720985113. PubMed ID: 33522306
[TBL] [Abstract][Full Text] [Related]
3. Effects of propofol on cancer development and chemotherapy: Potential mechanisms.
Jiang S; Liu Y; Huang L; Zhang F; Kang R
Eur J Pharmacol; 2018 Jul; 831():46-51. PubMed ID: 29654781
[TBL] [Abstract][Full Text] [Related]
4. New perspectives on the use of propofol.
Birka A
Crit Care Nurse; 1999 Aug; 19(4):18-9. PubMed ID: 10614243
[No Abstract] [Full Text] [Related]
5. Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation.
Fulton B; Sorkin EM
Drugs; 1995 Oct; 50(4):636-57. PubMed ID: 8536552
[TBL] [Abstract][Full Text] [Related]
6. Use of propofol for alcohol withdrawal delirium: a case report.
Takeshita J
J Clin Psychiatry; 2004 Jan; 65(1):134-5. PubMed ID: 14974494
[No Abstract] [Full Text] [Related]
7. Propofol, but not ketamine or midazolam, exerts neuroprotection after ischaemic injury by inhibition of Toll-like receptor 4 and nuclear factor kappa-light-chain-enhancer of activated B-cell signalling: A combined in vitro and animal study.
Ulbrich F; Eisert L; Buerkle H; Goebel U; Schallner N
Eur J Anaesthesiol; 2016 Sep; 33(9):670-80. PubMed ID: 26981881
[TBL] [Abstract][Full Text] [Related]
8. Propofol.
Moos DD
Gastroenterol Nurs; 2006; 29(2):176-8. PubMed ID: 16609312
[No Abstract] [Full Text] [Related]
9. Fospropofol disodium for sedation.
Campion ME; Gan TJ
Drugs Today (Barc); 2009 Aug; 45(8):567-76. PubMed ID: 19927223
[TBL] [Abstract][Full Text] [Related]
10. Propofol participates in gastric mucosal protection through inhibiting the toll-like receptor-4/nuclear factor kappa-B signaling pathway.
Ye HH; Wu KJ; Fei SJ; Zhang XW; Liu HX; Zhang JL; Zhang YM
Clin Res Hepatol Gastroenterol; 2013 Feb; 37(1):e3-15. PubMed ID: 22516481
[TBL] [Abstract][Full Text] [Related]
11. Liver nitrosation and inflammation in septic rats were suppressed by propofol via downregulating TLR4/NF-κB-mediated iNOS and IL-6 gene expressions.
Wu GJ; Lin YW; Chuang CY; Tsai HC; Chen RM
Life Sci; 2018 Feb; 195():25-32. PubMed ID: 29307523
[TBL] [Abstract][Full Text] [Related]
12. Use of propofol and other nonbenzodiazepine sedatives in the intensive care unit.
Angelini G; Ketzler JT; Coursin DB
Crit Care Clin; 2001 Oct; 17(4):863-80. PubMed ID: 11762265
[TBL] [Abstract][Full Text] [Related]
13. Sinusal reversion of supraventricular tachyarrhythmias after propofol administration. A case series.
Montero-Tinnirello J; Magaldi M; Fontanals J; Masgoret P; Bravo JC
Med Intensiva; 2017 Nov; 41(8):499-501. PubMed ID: 28027785
[No Abstract] [Full Text] [Related]
14. Propofol post-conditioning alleviates hepatic ischaemia reperfusion injury via BRG1-mediated Nrf2/HO-1 transcriptional activation in human and mice.
Ge M; Chen H; Zhu Q; Cai J; Chen C; Yuan D; Jin Y; Yao W; Hei Z
J Cell Mol Med; 2017 Dec; 21(12):3693-3704. PubMed ID: 28749008
[TBL] [Abstract][Full Text] [Related]
15. The misuse and abuse of propofol.
Monroe T; Hamza H; Stocks G; Scimeca PD; Cowan R
Subst Use Misuse; 2011; 46(9):1199-205. PubMed ID: 21463203
[TBL] [Abstract][Full Text] [Related]
16. Refractory status epilepticus.
Golf M; Paice JA; Feulner E; O'Leary C; Marcotte S; Mulcahy M
J Palliat Med; 2004 Feb; 7(1):85-8. PubMed ID: 15000791
[No Abstract] [Full Text] [Related]
17. Propofol Total Intravenous Anesthesia as an Intervention for Severe Radiation-Induced Phantosmia in an Adolescent with Ependymoma.
Raghavan KC; Camfield AS; Lucas J; Ismael Y; Rossi MG; Anghelescu DL
J Adolesc Young Adult Oncol; 2020 Apr; 9(2):299-302. PubMed ID: 31644320
[TBL] [Abstract][Full Text] [Related]
18. Propofol reduces pulmonary edema by prevention of cytokine-mediated impairment of alveolar ion and fluid transport.
Eisenhut M
Pulm Pharmacol Ther; 2007; 20(5):493. PubMed ID: 17126574
[No Abstract] [Full Text] [Related]
19. Propofol in chemotherapy-associated nausea and vomiting.
Phelps KC; Restino MS
Ann Pharmacother; 1996 Mar; 30(3):290-2. PubMed ID: 8833566
[TBL] [Abstract][Full Text] [Related]
20. Recommendations for the Use of Propofol in Egg-Allergic Patients.
Martínez S; Lasa EM; Joral A; Infante S; Perez R; Ibáñez MD;
J Investig Allergol Clin Immunol; 2019 Feb; 29(1):72-74. PubMed ID: 30785111
[No Abstract] [Full Text] [Related]
[Next] [New Search]
